Cargando…

Influenza immunization and COVID-19—can viral structure be responsible for the effect?

Detalles Bibliográficos
Autores principales:	Ilic, Ivan, Stojanovic, Dragana Unic, Loncar, Goran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312082/ https://www.ncbi.nlm.nih.gov/pubmed/34325043 http://dx.doi.org/10.1016/j.ijid.2021.07.055

Ejemplares similares

Pneumonia in medical professionals during COVID-19 outbreak in cardiovascular hospital
por: Ilic, Ivan, et al.
Publicado: (2021)

Can Coinfection With Influenza Worsen COVID-19 Outcomes?
por: Suwanwongse, Kulachanya, et al.
Publicado: (2020)

Can India develop herd immunity against COVID-19?
por: Gowrisankar, A., et al.
Publicado: (2020)

COVID-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall
por: Balaphas, Alexandre, et al.
Publicado: (2020)

Letter in response to the article “Enhancing immunity in viral infections, with special emphasis on COVID-19: A review” (Jayawardena et al.)
por: Santacroce, Luigi
Publicado: (2020)

Unintended Consequence: Influenza plunges with public health response to COVID-19 in Singapore
por: Chow, Angela, et al.
Publicado: (2020)

Pre-vaccination immune response to COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Nasal lavage containing Angiotensin-Converting Enzyme-2 agonist can prevent and reduce viral load in COVID-19
por: Vofo, Gaelle, et al.
Publicado: (2020)

Response to Letter Regarding “A Case Series of Patients Coinfected With Influenza and COVID-19”
por: Naramala, Srikanth, et al.
Publicado: (2020)

Response to the letter of L. Santacroce regarding article “Enhancing immunity in viral infections, with special emphasis on COVID-19: A review” (Jayawardena et al.)
por: Jayawardena, Ranil, et al.
Publicado: (2020)

Dysregulated adaptive immune response contributes to severe COVID-19
por: Yu, Kuai, et al.
Publicado: (2020)

COVID-19 vaccine immune response and plasma cell dyscrasia
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Hydrocephalus Caused by H3N2 Type A Influenza Virus or Cerebellopontine Angle Schwannoma?
por: Nemir, Jakob, et al.
Publicado: (2017)

Response to Letter to the Editor: Spinomedullary Weston Hurst Syndrome After COVID-19 and Influenza Co-Infection
por: Hutto, Spencer K., et al.
Publicado: (2022)

Influenza immunization and surveillance in Saudi Arabia
por: Hashem, Anwar M.
Publicado: (2016)

Viral culture, genome characterization, and mutation analysis of human influenza A virus
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Chorea Hyperglycemia Basal Ganglia Syndrome—A Rare Case of Bilateral Chorea-Ballismus in Acute Non-Ketotic Hyperglycemia
por: Ilic, Aleksandra, et al.
Publicado: (2021)

Into the looking glass: Post-viral syndrome post COVID-19
por: Perrin, Ray, et al.
Publicado: (2020)

Anti-viral properties of antipsychotic medications in the time of COVID-19
por: Girgis, Ragy R., et al.
Publicado: (2021)

Viral shedding in tears of COVID-19 cases presenting as conjunctivitis
por: Goel, Ruchi, et al.
Publicado: (2020)

Viral genome sequencing for Defining Re-infection with COVID-19
por: Ananthan, Velmurugan Anbu
Publicado: (2021)

Positive effects of COVID-19 control measures on influenza prevention
por: Wu, Di, et al.
Publicado: (2020)

Comparison of Deaths from COVID-19 and Seasonal Influenza in the USA
por: Jeganathan, Niranjan, et al.
Publicado: (2021)

COVID-19 and seasonal influenza: The potential 2021–22 “Twindemic”
por: Bellizzi, Saverio, et al.
Publicado: (2022)

COVID-19 Vaccine-Induced Immune Response in Oral Fluids and Serum: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

COVID-19 Response in Sub-Saharan Africa: Lessons From Uganda
por: Lumu, Ivan
Publicado: (2020)

Can antipsychotic use protect from COVID-19?
por: Dratcu, Luiz, et al.
Publicado: (2021)

A CRISPR evolutionary arms race: structural insights into viral anti-CRISPR/Cas responses
por: Wang, Jiuyu, et al.
Publicado: (2016)

Response to “Potential for bias in assessing risk and protective factors for COVID-19: Commentary on Conlon et al.’s ‘Impact of the influenza vaccination on COVID-19 infection rates and Severity’”
por: Conlon, Anna, et al.
Publicado: (2021)

Influenza and Local Immunity
por: Whitby, Charles J.
Publicado: (1907)

Battle with COVID-19 in Iran: What lessons can be learned from the implementation of response strategies so far?
por: Amir-Behghadami, Mehrdad, et al.
Publicado: (2020)

Coagulopathy profiles and their correlation with molecular viral burden in patients with COVID-19
por: Park, Hee Sue, et al.
Publicado: (2021)

Comparing COVID-19-linked neurological complications with other viral infections
por: Deng, Xiao, et al.
Publicado: (2020)

COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?
por: Movahedi, Nasim, et al.
Publicado: (2021)

Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)

Decrease in viral hepatitis diagnoses during the COVID-19 pandemic in the Netherlands
por: Sonneveld, Milan J., et al.
Publicado: (2022)

Severe complicated influenza declined during the prevention of COVID-19 in Taiwan
por: Yang, Chih-Jen, et al.
Publicado: (2020)

Observing willingness of obtaining the influenza vaccine during and after COVID-19
por: Veluri, Nikhila, et al.
Publicado: (2020)

Influenza and anosmia: Important prediction factors for severity and death of COVID-19
por: Kim, Doo Hwan, et al.
Publicado: (2021)

Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19
por: Masiá, Mar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_le00e825b3a0lflimgmvij2p02